These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)

45
9
Favorite

These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)

Motley Fool2021-09-13

For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（9）

suetyee
·2021-09-14
Buy
Reply
2
Report
WLtan
·2021-09-14
Great
Reply
1
Report
MengKeng
·2021-09-14
Hooray for those who have these stocks and will make money out of it. For those who dun have like me, buy when dipping as it is long term investment. Haha
Reply
2
Report
Fold Replies
- MengKeng:
  Personally， the world is moving too fast and furious. We should be able to see good results within 3 - 5
  2021-09-14
  Reply
  Report
- 手可摘棉花:
  Ya but 7 years is a realllLllly loOoOoonG time.
  2021-09-14
  Reply
  Report
KYLeong
·2021-09-14
Buy and hold
Reply
1
Report
Fold Replies
- WLtan:
  great
  2021-09-14
  Reply
  Report
andrew123
·2021-09-14
Wow.. sure or not
Reply
Like
Report
Andersonkana
·2021-09-13
Good
Reply
1
Report
Andersonkana
·2021-09-13
Good
Reply
3
Report
chaisiewling
·2021-09-13
Like
Reply
2
Report
Fold Replies
- chaisiewling:
  Like
  2021-09-13
  Reply
  Report
五指神獭
·2021-09-13
Really!?!
Reply
4
Report
Fold Replies
- Starbucks:
  Seems so! $Salesforce.com(CRM)$ $Visa(V)$
  2021-09-13
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2167386583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-13 22:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2167386583","market":"us","top_or_hot":-1,"title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","media":"Motley Fool","content":"<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UNH","symbol_name":"联合健康","start_time":0,"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","article_id":"2167386583","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","pubTimestamp":1631543432,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Of the Dow's 30 components, these four could be its biggest winners.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"translate_title":"这4只道指股票可以在7年内（或更短时间内）让你的钱翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRM":0.9,"UNH":0.9,"V":0.9,"WBA":0.9},"content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":886780995,"gmtCreate":1631626186317,"gmtModify":1676530593042,"author":{"id":"4087554958389370","authorId":"4087554958389370","name":"suetyee","avatar":"https://static.tigerbbs.com/bd19cd2dd51b79773e0fab6bfd14cd60","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087554958389370","authorIdStr":"4087554958389370"},"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886780995","repostId":2167386583,"repostType":2,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886169564,"gmtCreate":1631575807758,"gmtModify":1676530577341,"author":{"id":"3581912064711553","authorId":"3581912064711553","name":"WLtan","avatar":"https://static.tigerbbs.com/354ffef504de8ee7159ec0ecd8769350","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3581912064711553","authorIdStr":"3581912064711553"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886169564","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886180011,"gmtCreate":1631575217533,"gmtModify":1676530577087,"author":{"id":"3582668988155006","authorId":"3582668988155006","name":"MengKeng","avatar":"https://static.tigerbbs.com/daf999525f61ba41d3c13b0ed728eb77","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582668988155006","authorIdStr":"3582668988155006"},"htmlText":"Hooray for those who have these stocks and will make money out of it.&nbsp; For those who dun have like me, buy when dipping as it is long term investment. Haha","listText":"Hooray for those who have these stocks and will make money out of it.&nbsp; For those who dun have like me, buy when dipping as it is long term investment. Haha","text":"Hooray for those who have these stocks and will make money out of it. For those who dun have like me, buy when dipping as it is long term investment. Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/886180011","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5859258,"gmtCreate":1631579464985,"gmtModify":1663233843225,"authorId":3582668988155006,"author":{"id":3582668988155006,"idStr":"3582668988155006","authorId":3582668988155006,"name":"MengKeng","avatar":"https://static.tigerbbs.com/daf999525f61ba41d3c13b0ed728eb77","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.11%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886180011,"type":1,"supId":5858374,"prevId":0,"content":"Personally， the world is moving too fast and furious.&nbsp; We should be able to see good results within 3 - 5","text":"Personally， the world is moving too fast and furious.&nbsp; We should be able to see good results within 3 - 5","html":"Personally， the world is moving too fast and furious.&nbsp; We should be able to see good results within 3 - 5"},{"id":5858374,"gmtCreate":1631577218519,"gmtModify":1663233838242,"authorId":3579342217954724,"author":{"id":3579342217954724,"idStr":"3579342217954724","authorId":3579342217954724,"name":"手可摘棉花","avatar":"https://static.tigerbbs.com/eb5d81ca4420febc27175fcd21eb90b2","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886180011,"type":1,"supId":0,"prevId":0,"content":"Ya but 7 years is a realllLllly loOoOoonG time.","text":"Ya but 7 years is a realllLllly loOoOoonG time.","html":"Ya but 7 years is a realllLllly loOoOoonG time."}],"langContent":"EN"},{"id":886375487,"gmtCreate":1631572035849,"gmtModify":1676530575850,"author":{"id":"3585654473355479","authorId":"3585654473355479","name":"KYLeong","avatar":"https://static.tigerbbs.com/111375adba6b10bddbeeb78b9ead7c80","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585654473355479","authorIdStr":"3585654473355479"},"htmlText":"Buy and hold","listText":"Buy and hold","text":"Buy and hold","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886375487","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5858029,"gmtCreate":1631575825894,"gmtModify":1663233838347,"authorId":3581912064711553,"author":{"id":3581912064711553,"idStr":"3581912064711553","authorId":3581912064711553,"name":"WLtan","avatar":"https://static.tigerbbs.com/354ffef504de8ee7159ec0ecd8769350","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886375487,"type":1,"supId":0,"prevId":0,"content":"great","text":"great","html":"great"}],"langContent":"EN"},{"id":886371849,"gmtCreate":1631571650081,"gmtModify":1676530575759,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"idStr":"3576260758860416","authorIdStr":"3576260758860416"},"htmlText":"Wow.. sure or not","listText":"Wow.. sure or not","text":"Wow.. sure or not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886371849","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886926863,"gmtCreate":1631544952552,"gmtModify":1676530572498,"author":{"id":"4088599389256890","authorId":"4088599389256890","name":"Andersonkana","avatar":"https://static.tigerbbs.com/21e08c99709245ba5acdcf7245d9c40f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088599389256890","authorIdStr":"4088599389256890"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886926863","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886928239,"gmtCreate":1631544926221,"gmtModify":1676530572481,"author":{"id":"4088599389256890","authorId":"4088599389256890","name":"Andersonkana","avatar":"https://static.tigerbbs.com/21e08c99709245ba5acdcf7245d9c40f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088599389256890","authorIdStr":"4088599389256890"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886928239","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":886929712,"gmtCreate":1631544755536,"gmtModify":1676530572343,"author":{"id":"3584578813080112","authorId":"3584578813080112","name":"chaisiewling","avatar":"https://static.tigerbbs.com/a9a4a1e448f0d39c51c24533166eb658","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584578813080112","authorIdStr":"3584578813080112"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886929712","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5855382,"gmtCreate":1631544765143,"gmtModify":1631887967314,"authorId":3584578813080112,"author":{"id":3584578813080112,"idStr":"3584578813080112","authorId":3584578813080112,"name":"chaisiewling","avatar":"https://static.tigerbbs.com/a9a4a1e448f0d39c51c24533166eb658","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886929712,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":886986966,"gmtCreate":1631543752255,"gmtModify":1676530571971,"author":{"id":"3549753214776437","authorId":"3549753214776437","name":"五指神獭","avatar":"https://static.tigerbbs.com/6bcfed8048a3809a7af76678043890a9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3549753214776437","authorIdStr":"3549753214776437"},"htmlText":"Really!?!","listText":"Really!?!","text":"Really!?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886986966","repostId":2167386583,"repostType":4,"repost":{"id":"2167386583","pubTimestamp":1631543432,"share":"https://ttm.financial/m/news/2167386583?lang=&edition=fundamental","pubTime":"2021-09-13 22:30","market":"us","language":"en","title":"These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)","url":"https://stock-news.laohu8.com/highlight/detail?id=2167386583","media":"Motley Fool","summary":"Of the Dow's 30 components, these four could be its biggest winners.","content":"<p>For more than 125 years, the iconic <b>Dow Jones Industrial Average</b> (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.</p>\n<p>Over the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.</p>\n<p>But investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Of the Dow's 30 components, the <a href=\"https://laohu8.com/S/AONE.U\">one</a> I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider <b>Salesforce.com</b> (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.</p>\n<p>The reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.</p>\n<p>Salesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a>. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.</p>\n<p>If Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fmale-patient-discussion-with-doctor-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>UnitedHealth Group</h2>\n<p>The great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why <b>UnitedHealth Group</b> (NYSE:UNH) is a good bet to double investors' money over the next seven years.</p>\n<p>Most folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.</p>\n<p>However, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.</p>\n<p>With sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fpharmacist-dispensing-drugs-patient-cost-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>Another healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.</p>\n<p>According to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.</p>\n<p>Arguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.</p>\n<p>At 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F642599%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>Last but not least, payment processing giant <b>Visa</b> (NYSE:V) can charge higher over the next seven years and double your money.</p>\n<p>The beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.</p>\n<p>Visa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.</p>\n<p>It happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 4 Dow Stocks Can Double Your Money in 7 Years (or Less)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 4 Dow Stocks Can Double Your Money in 7 Years (or Less)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UNH":"联合健康","CRM":"赛富时","WBA":"沃尔格林联合博姿","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/13/these-4-dow-stocks-can-double-your-money-7-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167386583","content_text":"For more than 125 years, the iconic Dow Jones Industrial Average (DJINDICES:^DJI) has served as a barometer for the health of the U.S. stock market. Comprised of 30 profitable and time-tested companies, the Dow Jones is the perfect example of how buy-and-hold investing can make investors rich.\nOver the trailing 50 years, the Dow has averaged an annualized return of about 7.5%. On a compounded basis, this means the Dow Jones Industrial Average is doubling roughly every 10 years.\nBut investors may not have to wait a full decade to see their initial investment double in value. The following four Dow stocks all have the potential to double investors' money over the next seven years, or perhaps even sooner.\nImage source: Getty Images.\nSalesforce\nOf the Dow's 30 components, the one I believe offers the best chance to double investors' money in seven years or less is cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM). For those wondering, CRM software is used by consumer-facing businesses to enhance client relationships and boost sales.\nThe reason Salesforce is such a no-brainer outperformer has to do with its dominant market share in global CRM. When IDC analyzed global CRM spending in the first half of 2020, it found that Salesforce gobbled up just shy of 20% of all sales. That's more than its four closest competitors, combined. It's the clear go-to platform for CRM, which is a sustainable double-digit growth opportunity as businesses digitize their operations.\nSalesforce has also done an excellent job of making earnings-accretive acquisitions. CEO Marc Benioff has overseen the buyouts of MuleSoft, Tableau, and most recently Slack Technologies. Buying cloud-based enterprise communications platform Slack gives Salesforce another jumping-off point with which to cross-sell its products and services, while exposing the company to a broader swath of small and medium-sized businesses.\nIf Benioff's projection is accurate, Salesforce will more than double its sales in five years to $50 billion.\nImage source: Getty Images.\nUnitedHealth Group\nThe great thing about healthcare stocks is that they're highly defensive. No matter how well or poorly the U.S. economy is performing, demand for drugs, devices, and healthcare services remains relatively steady. That's why UnitedHealth Group (NYSE:UNH) is a good bet to double investors' money over the next seven years.\nMost folks are probably familiar with UnitedHealth's insurance operations. Health insurance isn't necessarily a fast-growing segment, but it does provide strong premium pricing power and the ability to grow profitability by a mid-single-digit percentage over time. If Democrats were to remain in control of Congress for years to come, an expansion of healthcare coverage could be a boon to UnitedHealth.\nHowever, the big-time long-term growth driver for UnitedHealth is its subsidiary Optum, which is a pharmacy-benefits manager and healthcare services company. Optum handles everything from pharmacy care services to data analytics for hospitals and healthcare organizations. Optum's sales are growing considerably faster than UnitedHealth's insurance segment, and its operating margins should be superior.\nWith sustainable sales growth of around 10% and a growing dividend, UnitedHealth Group could be just what the doctor ordered.\nImage source: Getty Images.\nWalgreens Boots Alliance\nAnother healthcare stock with all the tools needed to double investors' money by 2028 or earlier is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Even though Walgreens and its pharmacy peers were clobbered by reduced foot traffic during the pandemic, the company's multipoint turnaround plan should have its business humming along in no time.\nAccording to management, Walgreens is ahead of schedule on the cost-saving front. The company expects to have reduced its annual operating expenses by at least $2 billion in fiscal 2022. All the while, significant investments are being made in Walgreens' digitization initiatives, which were accelerated during the pandemic. Although direct-to-consumer sales still take a back seat to in-store purchases, online sales should be a sustainable rapid growth opportunity for the company.\nArguably the most exciting aspect of Walgreens' turnaround strategy is its partnership with VillageMD. This duo plans to open as many as 700 full-service clinics co-located in Walgreens' stores in more than 30 U.S. markets. Since most in-store clinics can only handle very simple tasks, such as vaccines, this initiative could be the key to drawing in repeat customers and funneling them to Walgreens' high-margin pharmacy.\nAt 10 times forward-year earnings per share, Walgreens Boots Alliance is currently one of the cheapest Dow stocks.\nImage source: Getty Images.\nVisa\nLast but not least, payment processing giant Visa (NYSE:V) can charge higher over the next seven years and double your money.\nThe beauty of the Visa operating model is that it's cyclical. Despite recessions being a normal part of the economic cycle, they often only last a few months or a couple of quarters. By comparison, periods of economic expansion typically go on for years, or even a decade. Visa is able to roll with the punches for a few quarters during a recession, but benefits immensely from disproportionately long periods of economic growth.\nVisa is also the most dominant player in the No. 1 market for consumption in the world: The United States. In 2018, it held a 53% share of credit card network purchase volume in the U.S., which was more than 30 percentage points higher than its next-closest competitor.\nIt happens to have a long runway for infrastructure expansion, too. Since most global transactions are still being conducted in cash, Visa has the opportunity to expand its infrastructure organically or through acquisition into emerging markets. This should allow Visa to maintain a growth rate near 10%, as well as a profit margin at or above 50%.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5855693,"gmtCreate":1631546199043,"gmtModify":1663233829959,"authorId":3573818563583937,"author":{"id":3573818563583937,"idStr":"3573818563583937","authorId":3573818563583937,"name":"Starbucks","avatar":"https://static.tigerbbs.com/adf9c30b19f3cc477ca4f1198d2c8b81","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":886986966,"type":1,"supId":0,"prevId":0,"content":"Seems so! <a href=\"https://laohu8.com/S/CRM\"> $Salesforce.com(CRM)$</a> <a href=\"https://laohu8.com/S/V\"> $Visa(V)$</a> ","text":"Seems so! <a href=\"https://laohu8.com/S/CRM\"> $Salesforce.com(CRM)$</a> <a href=\"https://laohu8.com/S/V\"> $Visa(V)$</a> ","html":"Seems so! <a href=\"https://laohu8.com/S/CRM\"> $Salesforce.com(CRM)$</a> <a href=\"https://laohu8.com/S/V\"> $Visa(V)$</a> "}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":45,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}